Previous studies using in vitro and mouse xenograft models revealed that bone marrow MSCs can accelerate tumor growth by increasing the self-renewal capacity (number) of breast cancer stem cells (CSCs), and this effect depends on the regulation of the intercellular IL-6/CXCL7 cytokine network (Liu et al., 2011). This evidence concerns the gene IL6 and breast carcinoma.